Atezolizumab Plus Bevacizumab in TMB-High Non-Small Cell Lung Cancers-The Hunt for Predictive Biomarkers to Optimize Treatment Selection. Ricciuti B, Awad MM. JAMA Oncol 2023;9:353-354.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ricciuti B, Awad MM. Atezolizumab Plus Bevacizumab in TMB-High Non-Small Cell Lung Cancers-The Hunt for Predictive Biomarkers to Optimize Treatment Selection. JAMA Oncol 2023;9:353-354.
PMID: 36520420